Add as a preferred source on GoogleJim Cramer’s Charitable Trust Plans to Trim Cardinal Health and Eli Lilly
The planned sales would leave the portfolio with 375 Cardinal Health shares and 70 Eli Lilly shares.
Jim Cramer’s Charitable Trust plans to trim its Cardinal Health and Eli Lilly holdings after both stocks rose more than 20% since late September, while retaining a position in each company.
The portfolio plans to sell 50 Cardinal Health shares for about $273 each, leaving it with 375 shares. It also plans to sell 10 Eli Lilly shares for about $1,420 each, leaving 70. The trades would reduce Cardinal Health’s portfolio weighting to 2.75% from 3% and Eli Lilly’s to 2.6% from 3%.
The planned sales would realize gains of 20% on Cardinal Health shares bought in March 2026 and 500% on Eli Lilly shares bought in February 2022.
Cardinal Health rose more than 4% Thursday after posting stronger-than-expected earnings and raising its full-year outlook. The gain extended its rally since the end of September. Eli Lilly was modestly higher after its stronger-than-expected results and outlook increase last week.
Health care stocks outperformed during Thursday’s market weakness as technology and data-center shares came under pressure. The trust plans to continue holding both companies, describing its health care investments as a way to diversify its portfolio from data-center stocks.